ALIMERA SCIENCES INC (29)

Browse by Contract Category

Contracts

Alimera Sciences, Inc. 2019 Omnibus Incentive Plan, as amended pursuant to stockholder approval on June 15, 2021 (Filed With SEC on June 16, 2021)
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 7, 2021)
Exclusive License Agreement by and between and Ocumension (Hong Kong) Limited, dated as of April 14, 2021 (Filed With SEC on April 14, 2021)
Description of Securities (Filed With SEC on March 5, 2021)
Manufacturing Services Agreement between Alimera Sciences, Inc. and Cadence, Inc. dated October 30, 2020 (including related Supplier Quality Agreement) (Filed With SEC on November 3, 2020)
Office Lease by and between Rubicon, L.C. and Alimera Sciences, Inc., dated as of May 27, 2003, as amended on various dates through August 14, 2014 (Filed With SEC on February 25, 2019)
Warrant Subscription Agreement by and between Alimera Sciences, Inc. and Ocumension Therapeutics, dated as of April 14, 2021 (Filed With SEC on April 14, 2021)
Voting and Investor Rights Agreement by and between Alimera Sciences, Inc. and Ocumension Therapeutics, dated as of April 14, 2021 (Filed With SEC on April 14, 2021)
Share Purchase Agreement by and between Ocumension Therapeutics and Alimera Sciences, Inc., dated as of April 14, 2021 (Filed With SEC on April 14, 2021)
Employment Agreement, dated as of July 27, 2020, by and between Alimera Sciences, Inc. and Samer E. Kaba, M.D (Filed With SEC on November 3, 2020)
Form of Restricted Stock Unit Agreement under the Alimera Sciences, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on May 6, 2020)
Form of Restricted Stock Agreement under the Alimera Sciences, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on May 6, 2020)
First Amendment to Restricted Stock Unit Award Agreement under 2010 Equity Incentive Plan of Richard S. Eiswirth, Jr (Filed With SEC on May 6, 2020)
First Amendment to Loan and Security Agreement dated as of May 1, 2020, by and among Alimera Sciences, Inc., Solar Capital Ltd., as Collateral Agent, and the parties signatory... (Filed With SEC on May 1, 2020)
Consent to Loan and Security Agreement dated as of April 21, 2020 by and among Alimera Sciences, Inc., Solar Capital Ltd., as collateral agent, and the Lenders parties thereto,... (Filed With SEC on April 23, 2020)
Loan Agreement dated April 21, 2020 between HSBC Bank USA, National Association and Alimera Sciences, Inc (Filed With SEC on April 23, 2020)
U.S. Small Business Administration Note dated April 21, 2020 of Alimera Sciences, Inc. in favor of HSBC Bank USA, National Association as the Lender (Filed With SEC on April 23, 2020)
Description of Securities (Filed With SEC on March 2, 2020)
Loan and Security Agreement dated as of December 31, 2019, by and among Alimera Sciences, Inc., Solar Capital Ltd., as Collateral Agent, and the parties signatory thereto from... (Filed With SEC on January 6, 2020)
Exit Fee Agreement dated as of December 31, 2019, by and among Alimera Sciences, Inc., Solar Capital Ltd. as collateral agent, and the Lenders (Filed With SEC on January 6, 2020)
Purchase Agreement, dated as of October 24, 2019, between Alimera Sciences, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 25, 2019)
Registration Rights Agreement, dated as of October 24, 2019, between Alimera Sciences, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 25, 2019)
Form of Alimera Sciences, Inc. Deduction Agreement (Filed With SEC on September 5, 2019)
Alimera Sciences, Inc. 2019 Non-Employee Director Compensation Program (Filed With SEC on July 19, 2019)
Form of Stock Option Agreement under the Alimera Sciences, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on June 19, 2019)
Alimera Sciences, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on June 19, 2019)
Amended and Restated Employment Agreement, dated as of January 2, 2019, by and between Alimera Sciences, Inc. and J. Philip Jones (Filed With SEC on May 8, 2019)
Amended and Restated Employment Agreement, dated as of January 2, 2019, by and between Alimera Sciences, Inc. and Richard S. Eiswirth, Jr (Filed With SEC on May 8, 2019)
Amended and Restated Succession and Consulting Agreement, dated as of March 27, 2019, by and between Alimera Sciences, Inc. and Kenneth Green, Ph.D (Filed With SEC on May 7, 2019)